Automated Versus Manual Cardiopulmonary Resuscitation in Flight: Are We Being Safe?

Objective: The primary purpose of this study was to compare the percentage of return of spontaneous circulation of in-flight cardiac arrest (IFCA) patients on admission to the emergency department (ED) who received in-flight standard cardiopulmonary resuscitation (s-CPR) versus automated cardiopulmonary resuscitation (a-CPR).

Setting: EMS helicopter (HEMS) service in Midwest USA.

Methods: This was a prospective, consecutive case series of adult patients who had IFCA of any cause managed with a-CPR between October 1, 2012, and February 8, 2016 (40 months), at a helicopter emergency medical service (HEMS) in the Midwestern United States.

Prehospital COVID-19-Related Encounters Predict Future Hospital Utilization.

Objective: Identify if prehospital patient encounters can predict SARS-CoV-2 (COVID-19) related hospital utilization.

Methods: EMS data from COVID-19-related prehospital encounters was pulled from NEMSIS systems in Minnesota. This data was plotted against hospital general medical-surgical bed and ICU bed usage during the initial COVID-19 surge and again during a second surge.

One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial).

The Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care Trial of very early intravenous glucose-insulin-potassium (GIK) for acute coronary syndromes (ACS) in out-of-hospital emergency medical service (EMS) settings showed 80% reduction in infarct size at 30 days, suggesting potential longer-term benefits. Here we report 1-year outcomes. Prespecified 1-year end points of this randomized, placebo-controlled, double-blind, effectiveness trial included all-cause mortality and composites including cardiac arrest, mortality, or hospitalization for heart failure (HF).

Use of the King LTS-D during medication-assisted airway management.

Objective: This case series evaluated provider use of the King LTS-D as a primary airway in patients requiring rapid-sequence intubation (RSI).

Methods: Twenty-seven paramedics completed a one-hour training session on the use of the device. All patients meeting the service's standard criteria for medication-assisted airway management were included in the study.

Use of the pediatric EZ-IO needle by emergency medical services providers.

Objective: The aim of this study was to examine emergency medical services providers' use of a new intraosseous needle designed for pediatric patients.

Methods: This prospective pilot study was conducted between May 2006 and October 2007. After completing an initial training session, the EZ-IO PD was deployed for use on patients.

Shock therapy. How donut magnets can suspend inappropriate ICD shocks.

EMS crews encounter implantable cardioverter defibrillators (ICDs) daily, but these encounters rarely involve ICDs firing repeatedly on an awake, alert and understandably frightened individual. But that's exactly what happened when an EMS crew from Cottage Grove, Minn., responded to a man with a known heart condition who reported that his implantable defibrillator was firing inappropriately.

Paramedic student adherence to the National Standard Curriculum recommendations.

Objectives: The National Standard Curriculum-Paramedic (NSC-P) is the accepted curriculum for paramedic programs across the country. The purpose of this study was to examine the completion of the NSC-P clinical internship recommendations by paramedic students.

Methods: Paramedic student internship experience data from 2001 to 2005 was retrospectively reviewed from FISDAPtrade mark.

Consecutive field trials using two different intraosseous devices.

Objective: Establishing traditional intravenous (IV) access in adult trauma and medical patients can be difficult. We evaluated provider performance for obtaining intraosseous access with two FDA-approved intraosseous devices (F.A.